Nugen technologies, INC.:1164879 [17-035373]
Ended Awarded
- Contract number
- HHSN26100002
- Awardee
-
Tecan Genomics, Inc. UEI R4DEKMG6K8N4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,900
Award facts
- Contract value 100% obligated
- $10,900.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Tecan Genomics, Inc. was awarded a $10,900 firm fixed-price call under a Blanket Purchase Agreement (BPA) by the National Cancer Institute on May 4, 2017, with an ultimate completion date of May 14, 2017. The contract was performed in Bethesda, Maryland and utilized no set-aside designation. As a Switzerland-based manufacturer specializing in life science laboratory automation and genomic research technologies, Tecan Genomics provides sophisticated scientific equipment and reagents to federal agencies, with particular expertise in RNA sequencing, genomic analysis, and infectious disease research applications.
This contract award represents a call against Tecan Genomics' larger $100 million single-award BPA with the Office of Logistics and Acquisition Operations, which was active through March 31, 2025. The BPA vehicle enables the company to supply biological materials and research products to multiple National Institutes of Health institutes and the Centers for Disease Control and Prevention, supporting critical research programs in infectious disease, genomics, and aging. Tecan Genomics has maintained consistent engagement with federal agencies through firm fixed-price purchase orders since 2004, delivering specialized equipment and reagents essential to the government's genomic and infectious disease research initiatives.
Quick answers
Who was awarded contract HHSN26100002?
HHSN26100002 was awarded to Tecan Genomics, Inc. by National Cancer Institute (National Institutes of Health) on May 4, 2017.
How much is contract HHSN26100002 worth?
The government has obligated $10,900 on HHSN26100002.
Is contract HHSN26100002 an order under another contract?
Yes. HHSN26100002 is a BPA call under HHSN263201300006B, a blanket purchase agreement.
Was contract HHSN26100002 competed?
The extent of competition for HHSN26100002 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award